Alessandro Fucili

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Inflammation, Allergy, Lung Inflammation +11

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 847 citations · Full text

Cardiovascular Toxicity, C-reactive Protein Reduction, Cardiovascular Disease +8

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski, Bridget‐Anne Kirwan, Stefan D. Anker et al. · The Lancet · 2020 · 723 citations · Full text

Heart Failure, Iron Metabolism, Clinical Nutrition +5

CD34 ⁺ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure

Marco Valgimigli, Gian Matteo Rigolin, Alessandro Fucili et al. · Circulation · 2004 · 374 citations · Full text

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure

Cristina Opasich, Mario Cazzola, Laura Scelsi et al. · European Heart Journal · 2005 · 287 citations